Medicine

Permanent URI for this communityhttp://repository.kln.ac.lk/handle/123456789/12

This repository contains the published and unpublished research of the Faculty of Medicine by the staff members of the faculty

Browse

Author: search.filters.author.Das, S.Has files: Yes

Search Results

Now showing 1 - 6 of 6
  • Thumbnail Image
    Item
    Bridging the gap: Policy recommendations to address suicides committed by Indigenous youth in Victoria
    (AccScience Publishing, 2024-12) Shoib, S.; Das, S.; Saeed, F.; Chandradasa, M.; Zaidi, I.
    The Aboriginal population comprises 3.3% of the total Australian population, and youth represent 19% of this segment. In general, the Aboriginal inhabitants of Australia experience discrimination, limited access to education, and low socioeconomic conditions, and exhibit high mental disorder rates. The rate of suicide attempts by the Indigenous people of Victoria increased by 75% in 2021. This study examined the possible risk factors associated with suicides committed by Indigenous youth in Victoria. It focused on the health profiles of Victorian Aboriginal individuals, identified stakeholders who could help improve their mental well-being, addressed the needs and issues related to Aboriginal mental health, and examined substance abuse in this population segment. Finally, recommendations are offered to mitigate the studied problem. Rising suicide rates represent an urgent concern because they reflect the diminished mental health conditions of a society, particularly among its marginalized populations. It is crucial to develop an integrated suicide prevention act that takes into account the biological, psychological, social, cultural, and spiritual determinants of this population.
  • Thumbnail Image
    Item
    Religion, spirituality, and coping among the psychiatric population: a narrative review
    (Academy Publisher, 2024) Shoib, S.; Das, S.; Gupta, A.K.; Ullah, I.; Javed, S.; Nocera, A.; Kar, S.K.; Chandradasa, M.; de Filippis, R.
    BACKGROUND AND AIMS: The impact of religiosity and spirituality on mental health is still far to be adequately explored. Evidence-based data gathering papers that bring together various perspectives and facets of religion in the mentally ill population is needed. Therefore, we conducted this review to summarise evidence on the subject and raise awareness. METHODS: We searched the literature using generic terms for ‘mental health and psychiatry’, ‘beliefs’, ‘religion’, ‘religious involvement’, ‘religiosity’, ‘spiritual aspects’, and ‘spirituality’, finally summarising all appropriate references. However, for this narrative revision, we collected papers addressing various perspectives, data, and facets of religion in the mentally ill population, a subject with theoretical and practical implications in mental health. RESULTS: The initial literature search found 21,723 total results: 1,723 from PubMed/Medline and Scopus, and up to 20,000 from Google Scholar, Science Direct, and Web of Science. After removing repetitions and applying inclusion and exclusion criteria, only six studies were included in this review on religion as an adaptive resource, and nine studies on religion, spirituality, and mental health. CONCLUSIONS: Evidence-based studies on the topic are still challenging to develop while maintaining a high scientific value. Notwithstanding this, religion and spirituality can have positive/negative clinical implications depending on how they are managed. Indeed, it can reduce suicidal risk, relieve depressive and anxious symptoms, and improve patients’ and caregivers’ coping and resilience. Nevertheless, it can enhance guilt, worsen/ generate obsessions, and compulsions in the obsessive-compulsive disorder and determine or associate with mystical-religious delusions in the maniacal phase of bipolar disorder.
  • Thumbnail Image
    Item
    Parity of esteem: A global COVID‑19 vaccination approach for people with mental illnesses, based on facts from 34 countries; recommendations and solutions
    (Medknow Publications, 2024) Shoib, S.; Saeed, F.; Philip, S.; Chandradasa, M.; Das, S.; de Filippis, R.; Yousaf, Z.; Ojeahere, M.; Gad, H.K.; Yadivel, R.; Legris, Z.; Jatchavala, C.; Paul, R.; Gupta, A.K.; Handuleh, J.I.M.; Gürcan, A.; Costa, M.P.D.; Dannatt, L.; Ahmad, A.R.; Jaguga, F.; Saleem, S.M.; Sawitri, B.; Ari, N.; Islam, M.S.; Haque, M.A.; Őri, D.; Chumakov, E.; Swed, S.; Roza, T.H.; Islam, S.M.S.
    BACKGROUND: The coronavirus disease (COVID 19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS CoV 2), has detrimental effects on physical and mental health. Patients with severe mental illness are at higher risk of contracting the virus due to social determinants of health. Vulnerable populations include the elderly, people with pre existing conditions, and those exposed to SARS CoV 2. Unfortunately, only a few countries have updated vaccination strategies to prioritize patients with mental illnesses. Therefore, we aimed to explore whether individuals with mental disorders are prioritized in vaccine allocation strategies in different world regions. They are often neglected in policymaking but are highly vulnerable to the threatening complications of COVID 19. METHODS: A questionnaire was developed to record details regarding COVID 19 vaccination and prioritizations for groups of persons with non communicable diseases (NCDs), mental disorders, and substance use disorders (SUDs). NCDs were defined according to the WHO as chronic diseases that are the result of a combination of genetic, physiological, environmental, and behavioral factors such as cardiovascular diseases, cancer, respiratory diseases, and diabetes. RESULTS: Most countries surveyed (80%) reported healthcare delivery via a nationalized health service. It was found that 82% of the countries had set up advisory groups, but only 26% included a mental health professional. Most frequently, malignancy (68%) was prioritized followed by diabetes type 2 (62%) and type 1 (59%). Only nine countries (26%) prioritized mental health conditions. CONCLUSION: The spread of the coronavirus has exposed both the strengths and flaws of our healthcare systems. The most vulnerable groups suffered the most and were hit first and faced most challenges. These findings raise awareness that patients with mental illnesses have been overlooked in immunization campaigns. The range of their mortality, morbidity, and quality of life could have widened due to this delay.
  • Thumbnail Image
    Item
    Prescribing Yoga for Mental Wellness: Need for a Nuanced Approach
    (Sage Publishing, 2024) Shoib, S.; Chandradasa, M.; Saleem, S.K.; Das, S.; Naqvi, S.A .A.; Kar, S.K.
  • Thumbnail Image
    Item
    Over-the-counter drug use in suicidal/self-harm behavior: Scoping review
    (John Wiley and Sons, 2022) Shoib, S.; Patel, V.; Khan, S.; Armiya'u, A.Y.; Saeed, F.; Swed, S.; Das, S.; Chandradasa, M.
    Background and aims: Minor physical ailments are treated with over-the-counter (OTC) medications. The availability of OTC drugs helps reduce waiting times and ease the suffering of many. Suicidal behavior includes suicidal ideation, attempts, and completed suicides and affects people of all ages, religions, and cultures. This study aims to review use of OTC drugs for self-harm and suicidal attempts. Methods: We reviewed English language publications from the beginning of time to October 2021 on OTC drug use for suicidal behavior. Results: Twenty-seven studies met the eligibility criteria, and 1,816,228 participants were reported in these publications. OTC analgesics and sedatives/hypnotics were frequently used for suicidal behavior. Females and young people mainly were reported to self-harm using OTC medications. An increase in OTC analgesic use for self-harm in adolescents during the school months was reported. Elderly persons use hypnotics more frequently for suicidal attempts. Persons with major psychiatric disorders were reported to use OTC for suicidal behavior. Conclusion: The available information shows that the prevention strategies should focus on OTC analgesics and hypnotic use among women, the young, the elderly, and persons with mental health disorders.
  • Thumbnail Image
    Item
    The disquietude of clozapine continuation during the COVID-19 pandemic.
    (John Wiley and Sons, 2022) Shoib, S.; Bharati-Sinha, V.; Javed, S.; Gürcan, A.; Gürcan, G.; Das, S.; Chandradasa, M.; Saeed, F.
    No abstract available
All items in this Institutional Repository are protected by copyright, with all rights reserved, unless otherwise indicated. No item in the repository may be reproduced for commercial or resale purposes.